Health Care: Drugs

Arrowhead Pharmaceuticals Inc (ARWR: NASDAQ)

$1.55 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Income Statement
Sep 2016 Sep 2015 Sep 2014 Sep 2013
Sales 158.33K 382.00K 175.00K 290.27K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 158.33K 382.00K 175.00K 290.27K
Selling, General, and Administrative Expenses 41.00M 34.72M 24.42M 11.69M
Research & Development 41.45M 47.27M 23.14M 8.71M
Operating Income before D & A (EBITDA) -82.29M -81.60M -47.38M -20.11M
Depreciation & Amortization 3.49M 3.45M 2.14M 1.88M
Interest Income 265.79K 729.16K 645.49K 0.00
Other Income - Net -243.67K 3.31M -6.01M -7.80M
Special Income / Charges 3.81M -22.18M -4.55M -1.31M
Total Income Before Interest Expenses (EBIT) -81.95M -93.05M -59.51M -31.73M
Interest Expense 0.00 0.00 0.00 97.91K
Pre-Tax Income -81.95M -93.05M -59.51M -31.83M
Income Taxes 2.40K 2.40K 5.30K 0.00
Minority Interest 0.00 0.00 -95.22K -560.14K
Net Income From Continuing Operations -81.72M -91.94M -58.73M -31.70M
Net Income From Discontinued Operations 0.00 0.00 0.00 -354.00
Net Income From Total Operations -81.72M -91.94M -58.73M -31.70M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -81.72M -91.94M -58.63M -31.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-85.53M -79.91M -54.18M -30.40M
Preferred Dividends
Net Income Available To Common -81.72M -91.94M -58.73M -31.70M
Basic EPS from Continuing Ops. -1.34 -1.60 -1.25 -1.30
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.34 -1.60 -1.25 -1.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.34 -1.60 -1.25 -1.30
Basic Normalized Net Income/Share -1.40 -1.39 -1.15 -1.24
EPS fr Continuing Ops. -1.34 -1.60 -1.25 -1.30
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.34 -1.60 -1.25 -1.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.34 -1.60 -1.25 -1.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.40 -1.39 -1.15 -1.24
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARWR

Latest ARWR Headlines from TheStreet

More Financial News for ARWR

Press Releases for ARWR

See All Press Releases

Partner Headlines for ARWR

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter